Browsing by Keyword : Cisplatin

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 48 of 48

Pub YearTitleAuthor(s)
2013A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.김유석, 임혜진, 정연훈
2015A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and Emesis.박동선
2017Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선
2022Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성
2001Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells.김승업, 최경숙
2022Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)최진혁
2000Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand.김승업, 최경숙, 허균
2019Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis이윤영, 장정훈, 정연훈, 추옥성
2017Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer노오규, 오영택, 장석준, 전미선, 조오연
2015Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.강대용
2006Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호
2016Connexin 43 Acts as a Proapoptotic Modulator in Cisplatin-Induced Auditory Cell Death김연주, 정연훈, 추옥성
2004Development of Biodegradable Polymer Releasing Anticancer Drug for Intratumoral Chemotherapy of Brain Tumor-in Vitro Results윤수한
2020Discovery of enhancing drugs that can prevent ototoxicity through cAMP signaling activity이진솔
2010Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.김세중
2010Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.김철호, 이진석, 정연훈
2016Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model손상용
2017FOXO3 induces ubiquitylation of AKT through MUL1 regulation김선용, 김철호
2021Gap junction-mediated intercellular communication of cAMP prevents CDDP-induced ototoxicity via cAMP/PKA/CREB pathway김연주, 김한태, 장정훈, 정연훈
2016Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial한상욱
2020Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer임선교
2014Gingko biloba extracts protect auditory hair cells from cisplatin-induced ototoxicity by inhibiting perturbation of gap junctional intercellular communication최성준
2019Growth arrest and DNA damage 45gamma is required for caspase-dependent renal tubular cell apoptosis신규태, 이화정
2017Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer노오규, 오영택, 유희석, 이은주, 장석준, 전미선, 조오연
2021Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival권요한, 김재근, 김진우, 원제환, 조효정, 허지미
2022Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)최진혁
2015Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.최진혁
2014Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.강성운, 김철호, 신유섭
2016Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)정성현
2007Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.-
2005Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.유희석, 이정필, 장기홍, 장혜진, 전미선
2014Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells.김연주, 임혜진, 전춘걸, 정연훈
2012Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer유희석, 장석준
2016Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer노오규, 오영택, 장석준, 전미선, 조오연
2015Protective effect of Artemisia asiatica (Pamp.) Nakai ex Kitam ethanol extract against cisplatin-induced apoptosis of human HaCaT keratinocytes: Involvement of NF-kappa B- and Bcl-2-controlled mitochondrial signaling.김연수, 김철호, 신유섭
2019Protective Effects of Serotonin and its Derivatives, N-Feruloylserotonin and N-(p-Coumaroyl) Serotonin, Against Cisplatin-Induced Renal Damage in Mice양시영
2019Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer최진혁
2006Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis.유희석, 이정필, 장기홍
2022Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model장석준
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial강석윤
1998Sensory Neural Hearing Loss after Concurrent Cisplatin and Radiation Therapy for Nasopharyngeal Carcinoma-
2004Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.강승희, 김철호, 오영택, 전미선, 최진혁
2021Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma조효정
2013Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer.김영배, 이다근, 한재호
2006The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis.강승희, 김효철, 박광주, 박준성, 신승수, 오영택, 오윤정, 이현우, 전미선, 최진혁, 황성철
2022The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study장석준
2014The Role of Connexin43 and Gap Junctional Intercellular Communication in the Apoptotic Process of Auditory Cells김연주
2020Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)최진혁
1

Browse